13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.
about
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancerAlternative medical treatment for radioiodine-refractory thyroid cancers.Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience.AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders.Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?Differentiated thyroid cancer-personalized therapies to prevent overtreatment.Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Novel targeted therapies and immunotherapy for advanced thyroid cancers.
P2860
Q24596266-385071A6-56D9-40C7-ADBA-892FECC89F8DQ33704599-6BEFDA53-A914-4C1F-A9DC-DE08966D708AQ35370655-382FE7D7-E0A0-493F-B9ED-4DDF9A5B38D0Q35969385-29ED3E15-3DAB-4C52-8055-47483DB92177Q36527774-CA798719-29A3-41D2-A689-CE7E73D0815AQ37915656-C2FE566C-5087-4CFD-8A03-C0E015BC2FC4Q37924944-BD506079-727E-4CE1-8508-E57354A71F1AQ38224994-87314205-9D17-44D6-A02D-40BD6DE116CDQ38675367-FEF0D9EB-B9D5-4F59-876E-E91B99066723Q38823954-78C52EDD-2F90-41B5-8D6A-07DA2C96603EQ38883187-4BFA3D9A-92D0-4016-A177-C0A579ABCC7EQ46073511-1EF09A48-051F-4927-842F-08479A19B77AQ49887965-95B44D91-8979-448D-9345-E973CF1B9FFB
P2860
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@ast
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@en
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@nl
type
label
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@ast
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@en
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@nl
prefLabel
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@ast
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@en
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@nl
P2093
P2860
P356
P1433
P1476
13-cis-retinoic acid re-differ ...... ter, 53-patient phase 2 study.
@en
P2093
Aleksandra Kukulska
Andrzej Piela
Daria Handkiewicz-Junak
Ewa Paliczka-Cieslik
Jozef Roskosz
Sylwia Szpak-Ulczok
Tomasz Olczyk
Zbigniew Puch
P2860
P2888
P356
10.1186/1756-6614-2-8
P577
2009-08-01T00:00:00Z
P5875
P6179
1029137457